Document is current
Any future updates will be listed below
-
Authors
Thomassen, Doranne https://orcid.org/0000-0002-9450-6015
Roychoudhury, Satrajit https://orcid.org/0000-0003-4001-3036
Amdal, Cecilie Delphin https://orcid.org/0000-0001-8422-8085
Reynders, Dries https://orcid.org/0000-0001-6875-048X
Musoro, Jammbe Z. https://orcid.org/0000-0002-6228-3531
Sauerbrei, Willi https://orcid.org/0000-0002-6792-4123
Goetghebeur, Els https://orcid.org/0000-0002-8896-0721
le Cessie, Saskia https://orcid.org/0000-0003-2154-4923
,
Kamalakar, Rajesh
Sail, Kavita
Basch, Ethan
Reijneveld, Jaap
Gerlinger, Christoph
Alanya, Ahu
Rumpold, Gerhard
Sasseville, Maxime
Black, Jennifer
Molenberghs, Geert
Rantell, Khadija
Schlichting, Michael
Regnault, Antoine
Ness, David
ten Seldam, Silene
Reksten, Tove Ragna
Schiel, Anja
Falk, Ragnhild Sorum
Campbell, Alicyn
Cappelleri, Joseph C.
Russell-Smith, Alexander
Calvert, Melanie
Cruz Rivera, Samantha
Aiyegbusi, Olalekan Lee
Liu, Limin
Van Lancker, Kelly
Rutherford, Claudia
Bhatnagar, Vishal
Chen, Ting-Yu
Fiero, Mallorie
Kluetz, Paul
-
Funding
Funding for this research was provided by:
European Union’s Horizon 2020 research and innovation programme and EFPIA (945052, 945052, 945052, 945052, 945052, 945052, 945052, 945052)
- License Information
-
More Information
Article History
Received: 30 September 2024
Accepted: 17 February 2025
First Online: 1 March 2025
Declarations
:
: No data were collected for the purpose of this study. Anonymized data from a previously published trial were shared with us for the illustration of analysis methods, respecting the informed consent previously provided by the trial participants.
: Not applicable.
: Satrajit Roychoudhury is an employee of Pfizer Inc., and a stockholder of Pfizer Inc. and Novartis Pharmaceutical. Els Goetghebeur and Dries Reynders contribute to a university-based statistical consulting service that has received limited consulting fees from Pfizer, no personal fees. There are no other potential conflicts of interests among our co-authors.
